Nov 23 2013
The spin-off from Joseph Fourier University, Grenoble (UJF), starts its incubation period accompanied by Grenoble’s innovation accelerators, Gravit and GATE1. Based on research by its leader, Prof. Jean Viallet (Associate Professor at UJF), the team intends to develop very promising in vivo assays for drug development, particularly for cancer treatments
Jul 6-9
2021
INOVOTION WILL ATTEND IMMUNO WEEK
DESIGNING AND DELIVERING INNOVATIVE IMMUNOTHERAPIES TO TRANSFORM CANCER CARE Immuno Week features four in-depth conference days, each with a different thematic focus crucial to the immuno-oncology industry. It brings together global pharmaceutical […]
Jun 10-18
2021
INOVOTION WILL ATTEND BIO DIGITAL
ACCELERATING A BIO-REVOLUTION THROUGH GLOBAL PARTNERSHIPS, COLLABORATION AND THROUGH LEADERSHIP Extended Week of Connections and Partnerships BIO Digital 2021 will convene leaders from across the biotech ecosystem for a re-imagined virtual experience. […]
Jun 10
2021
INOVOTION'S NEW ASSAYS
A NEW APPROACH TO ANGIOGENESIS INOVOTION has two new in vivo assays for Angiogenesis! Our R&D team has recently remastered and validated two highly specific new assays based on the chicken Chorio-Allantoic Membrane (CAM). The chicken embryo […]
